BioSpace News Archive

Business

Egalet Partners With OraPharma to Co-Promote SPRIX Nasal Spray

SPRIX Nasal Spray is a NSAID indicated for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level.

January 3, 2018
·
12 min read
BioMidwest

Spectrum Brands’ Rayovac Introduces New PRO LINE® Advanced

Rayovac’s new PRO LINE Advanced combines long lasting power with an easy to use package.

January 3, 2018
·
5 min read
Drug Development

Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C

Ardelyx today announced that the company successfully completed the safety extension portion of its Phase 3 T3MPO program, designed to support the registration of tenapanor for the treatment of patients with IBS-C.

January 3, 2018
·
5 min read
Business

Merck to Hold Fourth-Quarter and Full-Year 2017 Sales and Earnings Conference Call on February 2

Merck will hold its fourth-quarter and full-year 2017 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Friday, February 2.

January 3, 2018
·
3 min read
Policy

Shire Canada Release: Xiidra* (Lifitegrast Ophthalmic Solution 5%) Approved by Health Canada To Treat the Signs and Symptoms of Dry Eye Disease

The approval of Xiidra is supported by the largest development program globally to-date for an investigational-stage dry eye disease therapy, consisting of five clinical trials with more than 2,500 patients.

January 3, 2018
·
7 min read
PlaqueTec Announces First Peer-Reviewed Publication for its Liquid Biopsy System (LBS)

PlaqueTec today announced the publication of the first peer-reviewed article demonstrating the feasibility and potential of the PlaqueTec Liquid Biopsy System to detect biomarkers for coronary artery disease.

January 3, 2018
·
5 min read
Business

Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings

Agenus announced new leadership appointments to enhance its team and advance combination clinical programs which will support its planned BLA filings in the second half of 2019 and in 2020.

January 3, 2018
·
5 min read
Business

Foresee and Megapharm Announce License and Distribution Agreement

Foresee and Megapharm announced today that they have entered into an exclusive license and distribution agreement for the commercialisation in Israel and the Palestinian Authority of Foresee’s FP-001 program.

January 3, 2018
·
3 min read
Genetown

ReadCoor Receives Grant From Chan Zuckerberg Initiative

ReadCoor announced a grant from the Chan Zuckerberg Initiative (CZI) and DAF, an advised fund of Silicon Valley Community Foundation, to spatially map cortical cells using Fluorescent in situ Sequencing (FISSEQ) for the Human Cell Atlas.

January 3, 2018
·
4 min read
Biotech Beach

PROCEPT BioRobotics Completes Enrollment in WATER II Pivotal Clinical Trial

The WATER II Study is a U.S. investigational device exemption (IDE) clinical trial evaluating the safety and efficacy of Aquablation therapy.

January 3, 2018
·
4 min read